Pemmaraju N, Herling M, Sweet KL, Stein AS, Vasu S, Rosenblat TL, Rizzieri DA, Papayannidis C, Wang ES, Konopleva M, Zuurman M, Tosolini A, Qazilbash M, Lane AA. First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level. Haematologica; https://doi.org/10.3324/haematol.2025.300036 [Early view].